336 related articles for article (PubMed ID: 9291104)
1. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.
Heyes MP; Chen CY; Major EO; Saito K
Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):351-6. PubMed ID: 9291104
[TBL] [Abstract][Full Text] [Related]
2. 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).
Saito K; Chen CY; Masana M; Crowley JS; Markey SP; Heyes MP
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):11-4. PubMed ID: 8471029
[TBL] [Abstract][Full Text] [Related]
3. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation.
Saito K; Nowak TS; Suyama K; Quearry BJ; Saito M; Crowley JS; Markey SP; Heyes MP
J Neurochem; 1993 Dec; 61(6):2061-70. PubMed ID: 8245962
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of L-tryptophan to kynurenate and quinolinate in the central nervous system: effects of 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Naritsin DB; Saito K; Markey SP; Chen CY; Heyes MP
J Neurochem; 1995 Nov; 65(5):2217-26. PubMed ID: 7595510
[TBL] [Abstract][Full Text] [Related]
6. Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain.
Kita T; Morrison PF; Heyes MP; Markey SP
J Neurochem; 2002 Jul; 82(2):258-68. PubMed ID: 12124427
[TBL] [Abstract][Full Text] [Related]
7. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
Saito K; Markey SP; Heyes MP
Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
[TBL] [Abstract][Full Text] [Related]
8. Species heterogeneity between gerbils and rats: quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation.
Heyes MP; Saito K; Chen CY; Proescholdt MG; Nowak TS; Li J; Beagles KE; Proescholdt MA; Zito MA; Kawai K; Markey SP
J Neurochem; 1997 Oct; 69(4):1519-29. PubMed ID: 9326281
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells.
Alberati-Giani D; Ricciardi-Castagnoli P; Köhler C; Cesura AM
J Neurochem; 1996 Mar; 66(3):996-1004. PubMed ID: 8769859
[TBL] [Abstract][Full Text] [Related]
10. Human microglia convert l-tryptophan into the neurotoxin quinolinic acid.
Heyes MP; Achim CL; Wiley CA; Major EO; Saito K; Markey SP
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):595-7. PubMed ID: 8973572
[TBL] [Abstract][Full Text] [Related]
11. 6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation.
Saito K; Markey SP; Heyes MP
Neurosci Lett; 1994 Sep; 178(2):211-5. PubMed ID: 7824198
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.
Saito K; Nowak TS; Markey SP; Heyes MP
J Neurochem; 1993 Jan; 60(1):180-92. PubMed ID: 8417138
[TBL] [Abstract][Full Text] [Related]
13. A mechanism for increased quinolinic acid formation following acute systemic immune stimulation.
Saito K; Crowley JS; Markey SP; Heyes MP
J Biol Chem; 1993 Jul; 268(21):15496-503. PubMed ID: 8340378
[TBL] [Abstract][Full Text] [Related]
14. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.
Guillemin GJ; Smythe G; Takikawa O; Brew BJ
Glia; 2005 Jan; 49(1):15-23. PubMed ID: 15390107
[TBL] [Abstract][Full Text] [Related]
15. Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice.
Saito K; Markey SP; Heyes MP
Brain Res; 1991 Apr; 546(1):151-4. PubMed ID: 1830237
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
Saito K; Fujigaki S; Heyes MP; Shibata K; Takemura M; Fujii H; Wada H; Noma A; Seishima M
Am J Physiol Renal Physiol; 2000 Sep; 279(3):F565-72. PubMed ID: 10966936
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the kynurenine pathway in human glioma pathophysiology.
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
[TBL] [Abstract][Full Text] [Related]
18. Kynurenine pathway metabolism in human astrocytes.
Guillemin GJ; Kerr SJ; Smythe GA; Armati PJ; Brew BJ
Adv Exp Med Biol; 1999; 467():125-31. PubMed ID: 10721049
[TBL] [Abstract][Full Text] [Related]
19. Kynurenine pathway enzymes in brain. Properties of enzymes and regulation of quinolinic acid synthesis.
Saito K; Heyes MP
Adv Exp Med Biol; 1996; 398():485-92. PubMed ID: 8906309
[No Abstract] [Full Text] [Related]
20. Regulation of the kynurenine pathway by IFN-gamma in murine cloned macrophages and microglial cells.
Alberati-Giani D; Ricciardi-Castagnoli P; Köhler C; Cesura AM
Adv Exp Med Biol; 1996; 398():171-5. PubMed ID: 8906262
[No Abstract] [Full Text] [Related]
[Next] [New Search]
